Myofascial Reorganization on Performance, and Biomechanical, Viscoelastic, and Thermographic Properties of Athletes

Launched by UNIVERSITY OF THE STATE OF SANTA CATARINA · Jun 26, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a technique called Myofascial Reorganization (RMF) to see how it affects running performance and certain physical properties (like flexibility and temperature) in male triathletes. The trial will compare the effects of this technique to a placebo, which is a treatment that does not have any active ingredients. Participants will undergo tests to measure their running ability and other physical characteristics before and after the six-week intervention, which includes sessions twice a week lasting about 30 minutes.

To be eligible for this trial, participants must be healthy male athletes aged 18 to 45 who have at least two years of competitive experience. They should train regularly, at least three times a week, and have no recent injuries or medical conditions that could affect their sports performance. If you join the study, you can expect to participate in a structured program aimed at improving your running and to undergo evaluations to track your progress. This is a great opportunity for athletes looking to enhance their performance while contributing to important research in sports science.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Athletes
• • Age between 18 and 45 years
• • 2 years of competitive experience
• • Non-smokers
• • Training at least 3 times/week intending to compete in at least local competitions
• • No presenting lower limb surgery in the last 12 months
• • Not presenting lower limb injury in the last 6 months
• • Not presenting cerebellar diseases that limit sportive practice
• • Not presenting brain diseases that limit sportive practice
• • Not presenting musculoskeletal diseases that limit sportive practice
• • Not presenting signs of rhabdomyolysis
• • Not presenting systemic conditions that limit sportive practice
• • Not presenting metabolic that limits sports practice
• • Not presenting autoimmune conditions;
• • Not presenting cardiac conditions.
• Exclusion Criteria:
• • Not accomplishing 83,3% (10 of 12 sessions) of the proposed experimental/placebo protocol
• • Not presenting themselves on the re-test day
• • Developing a lower limb musculoskeletal injury during the study's ongoing period.
• • Developing a back injury during the study's ongoing period?
• • Developing central or peripheral nervous system conditions during the study's ongoing period.